TYMLOS "Osteoferocious" Campaign

​

TYLMOS is a bone-building (anabolic) medication for women with postmenopausal osteoporosis at high risk for fracture. The brand launched in 2017 against steep competition. We knew we needed something bold and breakthrough to cut through the clutter—and to better connect with women over 50 who are still active, working, and in the prime of their lives.

 

Click on a social icon below to see more from the TYMLOS "Osteoferocious" campaign.